We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Painkiller Linked to Overdose Deaths

By HospiMedica staff writers
Posted on 11 Dec 2001
Following a review of autopsy data, officials of the US Drug Enforcement Administration (DEA) have concluded that the painkiller OxyContin was a factor in the overdose deaths of 110 people over the last 19 months. The study did not attempt to determine whether the drug alone was responsible for the deaths since the deaths involved multiple drugs.

Previously, overdose deaths by people taking OxyContin were believed to have been caused by people snorting or injecting crushed pills, a faster and more dangerous way to take the drug. However, the federal review showed that almost all of the overdose deaths were of people who had swallowed OxyContin whole or crushed into powder. Since the beginning of 2000, federal officials say around 500 people have died from overdoses involving oxycodone, the addictive narcotic in the drug and in other painkillers. However, they were unable to determine if all the overdoses were caused by OxyContin.

Recently, the manufacturer of OxyContin, Purdue Pharma L.P. (Stamford, CT) announced the beginning of clinical studies of a new drug containing oxycodone in a controlled-release formulation with an opiod antagonist, naloxone. The new version is designed to reduce intravenous abuse of OxyContin tablets. If the tablet is crushed and injected, the naloxone is released into the bloodstream, where it counteracts the effect of the oxycodone, diminishing the euphoria sought by the abuser. However, the recent findings that almost all the OxyContin-linked overdose deaths were of people who swallowed the drug would appear to indicate that this new version of OxyContin may not solve the abuse problem.




Related Links:
Purdue Pharma

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Phlebotomy Chair
CHE03/BH
New
Pediatric Cart
UXGLA-9PEDS

Latest Critical Care News

Breakthrough Technique Stops Irregular Heartbeats

AI Model Accurately Predicts Progression of Autoimmune Disease

AI Predicts and Identifies Subtypes of Type 2 Diabetes from Continuous Blood Glucose Monitor